AI, quantum, and biotech are becoming one stack.
An AI-designed drug just entered Phase III. Quantum systems are simulating real biology. ETA tracks where the three fields meet, what is proven, and what it means for talent, regions, and every organization adopting AI.
Updated November 8, 2026 · Stats checked weekly, stories added daily
Read the analysis
Feature · November 8, 2026The Convergence Era: Where AI, Quantum, and Biotech MeetAn AI-designed drug just entered Phase III. IBM switched on its most advanced quantum system in Chicago. The three most important technologies of the decade are starting to work as one stack.Read the feature
The First AI-Designed Drug Enters Phase III
Rentosertib is the first drug with an AI-discovered target and an AI-generated molecule to reach the final stage of human testing. Here is why that matters, and why it is not yet proof.
Quantum's Useful Era Starts With Hybrid
Quantum computers will not replace supercomputers or AI. In life sciences, they are becoming a third engine that works alongside both.
Latest news
Curated by ETA, each story with our take on what it means for leaders adopting AI.
- QuantumQuantum Computing ReportNov 6, 2026
NQCC Signs Enterprise Agreement with Phasecraft to Provide Quantum Software via SparQ Access (opens on Quantum Computing Report)
ETA take: The UK's national quantum centre is giving organizations shared access to Phasecraft's software. Leaders can test quantum advantage claims against their own problems before committing budget or hiring.
- QuantumIBM NewsroomNov 6, 2026
IBM switches on a Quantum System Two in Chicago to power a National Quantum Algorithm Center (opens on IBM Newsroom)
ETA take: Access for non-quantum companies is the headline. Regions that pair quantum with life sciences will pull talent.
- EventsPR NewswireOct 29, 2026
Entangled 2026 summit brings AI, quantum, and biotech leaders to Kendall Square on Nov 19 (opens on PR Newswire)
ETA take: Convergence is now a convening category. Expect more cross-sector events, and more cross-sector deals.
- QuantumThe Quantum InsiderOct 26, 2026
UK's National Quantum Computing Centre moves six of its seven quantum testbeds into independent evaluation (opens on The Quantum Insider)
ETA take: Governments are funding hands-on access. Testbeds are the cheapest way for organizations to learn before they buy.
- QuantumQuantinuumOct 18, 2026
Quantinuum reports a logical qubit nearly 100 times better than its physical qubits (opens on Quantinuum)
ETA take: Error correction is the gate to useful scale. Quantinuum now targets fault-tolerant computing by 2029.
- AI x BioPR NewswireOct 15, 2026
Insilico doses the first patient in a Phase III trial of a generative AI-designed drug (opens on PR Newswire)
ETA take: The first true late-stage test of AI drug discovery. Results will shape investment across the field for years.
- AI x BioForbesSep 30, 2026
Hybrid quantum simulation of photodynamic cancer therapy wins Wellcome Leap’s Quantum for Bio challenge (opens on Forbes)
ETA take: Algorithmiq, Cleveland Clinic, and IBM showed biologically meaningful chemistry on real quantum hardware.
- AI x BioIntuitionLabsJul 31, 2026
More than 173 AI-designed drug programs are now in clinical development (opens on IntuitionLabs)
ETA take: Up from about two dozen in late 2023. AI discovery is an industry pipeline, but Phase II failure rates have not improved yet.
Common questions
What does AI, quantum, and biotech convergence mean?
The shift from three separate fields to one workflow: AI generates candidates, quantum and classical computers simulate them, and biology validates and feeds results back.
Has an AI-designed drug been approved?
Not yet. Insilico Medicine’s rentosertib entered Phase III in October 2026, the furthest any generative AI-designed drug has reached.
Is quantum computing useful for drug discovery today?
In narrow, hybrid workflows, yes, alongside classical HPC and AI. Broad advantage awaits fault-tolerant machines.
How should my organization prepare?
Identify quantum-shaped problems, get hands-on through cloud access, inventory encryption for post-quantum migration, and cross-train a small team.
Keep exploring
AI Agents at WorkAI agents are clocking in. Is your team ready?40% Respondents at organizations above $1B revenue that report scaling AI agents in 2026, up from 27% a year earlier (McKinsey)Explore the hub
AI Power and the GridElectricity is now the limit on AI growth17% Growth in global data center electricity use in 2025, vs 3% for all electricity demand (IEA)Explore the hub
Physical AI and Humanoid RobotsPhysical AI leaves the lab for the factory floor5M Industrial robots operating in factories worldwide in 2025, a record, after installations rose 11% (IFR)Explore the hub
AI in SpaceThe cloud is leaving the ground.21 of 53 orbital data center programs have flown their own hardwareExplore the hubTake this conversation in person
Meet the leaders putting emerging tech to work at AI Week, produced by Enterprise Technology Association, and the US AI Congress.
Get hot topics by email.
New ETA analysis and the stories that matter, in the ETA member digest.